Hanwen Zhang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Dendritic Cells

Endoplasmic Reticulum

Top Venues

Cancer research

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Tenzin Passang, Shuhua Wang, Hanwen Zhang, Fanyuan Zeng, Po-Chih Hsu, Wenxi Wang, Jian-Ming Li, Yuan Liu, Sruthi Ravindranathan, Gregory B Lesinski, Edmund K Waller
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer. Cancer research (2024)
Yuki Kuranaga, Bing Yu, Satoru Osuka, Hanwen Zhang, Narra S Devi, Sejong Bae, Erwin G Van Meir
Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis. Cells 13 (9) (2024)
Yuki Kuranaga, Bing Yu, Satoru Osuka, Hanwen Zhang, Narra S Devi, Sejong Bae, Erwin G Van Meir
Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis. Cells 13 (9) (2024)
Yuki Kuranaga, Bing Yu, Satoru Osuka, Hanwen Zhang, Narra S Devi, Sejong Bae, Erwin G Van Meir
Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis. Cells 13 (9) (2024)
Chenhao Jiang, Huaxin Chen, Yinqian Kang, Xinyi He, Jianyang Huang, Tongyu Lu, Xin Sui, Haitian Chen, Jiaqi Xiao, Jiebin Zhang, Hanwen Zhang, Jun Zheng, Yang Yang, Jia Yao, Jianye Cai, Yingcai Zhang
Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis. Cell death discovery 9 (1) (2023)
Jingru Zhu, Yitong Wang, Jingxia Li, Pankoj Kumar Das, Hanwen Zhang, Tenzin Passang, Jian Ming Li, Tamas Nagy, Khanjan Gandhi, Sruthi Ravindranathan, Cynthia R Giver, Mojibade Hassan, Yiwen Li, Alina Ulezko Antonova, Shuhua Wang, John D Roback, Edmund K Waller
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression. Blood 140 (12) (2022)
Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, Shuhua Wang, Rohan Dhamsania, Michael Brandon Ware, Mohammad Y Zaidi, Jingru Zhu, Maria Andrea Cardenas, Yuan Liu, Sanjeev Gumber, Brian Robinson, Anish Sen-Majumdar, Hanwen Zhang, Shanmuganathan Chandrakasan, Haydn T Kissick, Alan B Frey, Susan Napier Thomas, Bassel F El-Rayes, Gregory B Lesinski, Edmund K Waller
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nature communications 13 (1) (2022)
Hanwen Zhang, Dan Zhu, Zhaobin Zhang, Stefan Kaluz, Bing Yu, Narra S Devi, Jeffrey J Olson, Erwin G Van Meir
EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway. Oncogene 39 (5) (2019)